Skip to content

Effect of HIIT Vs Moderate Intensity Aerobic Exercise on Insulin Resistance in Type 2 DM

Effect of High Intensity Interval Training Versus Moderate Intensity Aerobic Exercise on Insulin Resistance in Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05902546
Enrollment
80
Registered
2023-06-15
Start date
2023-01-07
Completion date
2023-09-30
Last updated
2023-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Insulin Resistance

Brief summary

Comparing between the efficacy of high intensity interval training and moderate intensity aerobic exercises on insulin resistance in type 2 Diabetes Mellitus.

Detailed description

The study aims at differentiating between high intensity interval training and moderate intensity continuous aerobic exercise in terms of their effect of Insulin resistance in patients diagnosed with type 2 Diabetes Mellitus. All participants will have lab analysis for Serum Homa-IR prior to intervention and after 1 month of treatment.

Interventions

OTHERHigh intensity interval training

Patients will receive interval training exercise of high intensity. This includes several rounds that alternate between several minutes of high intensity movements to significantly increase the heart rate to at least 80% of one's maximum heart rate, followed by short periods of rest

Patients will receive moderate intensity continuous aerobic exercise (walking) for 40 minutes (preceded by 10 minutes warming up and followed by 5 minutes cooling down)

Sponsors

Ahmed Maher Teaching Hospital
CollaboratorOTHER_GOV
Badr University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Type 2 Diabetes Mellitus Patients. * Diagnosed for more than 1 years at the time of the study. * Patients with fair control of blood glucose using hypoglycemic drugs

Exclusion criteria

* Type 1 (Insulin Dependant) Diabetes Mellitus patients. * Patients with disability that can't perform exercises. * Patient with known Cardiovascular diseases. * Patients with kidney/liver diseases

Design outcomes

Primary

MeasureTime frameDescription
Insulin Resistance (Homa-IR)1 monthSerum insulin resistance indicator (Homa-IR)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026